| 6CQ Stock | | | EUR 0.70 0.05 6.67% |
CEO
Charles Bachtell is Chief Executive Officer, Director of Cresco Labs since 2019.
| Age | 44 |
| Tenure | 6 years |
| Phone | 312 929 0993 |
| Web | https://www.crescolabs.com |
Cresco Labs Management Efficiency
The company has return on total asset
(ROA) of
0.0399 % which means that it generated a profit of $0.0399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.0635) %, meaning that it generated substantial loss on money invested by shareholders. Cresco Labs' management efficiency ratios could be used to measure how well Cresco Labs manages its routine affairs as well as how well it operates its assets and liabilities.
Cresco Labs has accumulated 465.08
M in total debt with debt to equity ratio
(D/E) of 0.44, which is about average as compared to similar companies. Cresco Labs has a current ratio of 1.48, which is within standard range for the sector. Debt can assist Cresco Labs until it has trouble settling it off, either with new capital or with free cash flow. So, Cresco Labs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cresco Labs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cresco to invest in growth at high rates of return. When we think about Cresco Labs' use of debt, we should always consider it together with cash and equity.
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It owns and operates 32 dispensaries, as well as 44 retail licenses. CRESCO LABS operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2900 people. Cresco Labs (6CQ) is traded on Frankfurt Exchange in Germany and employs 3,300 people.
Management Performance
Cresco Labs Leadership Team
Elected by the shareholders, the Cresco Labs' board of directors comprises two types of representatives: Cresco Labs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cresco. The board's role is to monitor Cresco Labs' management team and ensure that shareholders' interests are well served. Cresco Labs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cresco Labs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Ellis, Chief Operating Officer | |
| Mo Dastagir, Chief Information Officer | |
| Charles Bachtell, Chief Executive Officer, Director | |
| Gerald Corcoran, Independent Director | |
| John Schetz, General Counsel | |
| Michele Roberts, Director | |
| Brenna CPA, Treasury Accounting | |
| Zach Marburger, Interim Officer | |
| Dennis Olis, Chief Financial Officer | |
| Gregory Butler, Chief Commercial Officer | |
| Randy Podolsky, Independent Director | |
| Angie Demchenko, Chief People Officer | |
| Robert Sampson, Independent Director | |
| Thomas Manning, Executive Chairman of the Board | |
| Ty Gent, Chief Officer | |
| Brian McCormack, Independent Director | |
| Jake Graves, Ma Relations | |
| Impola Kelli, VP Compliance | |
| John Walter, Independent Director | |
| Jason Erkes, Chief Communications Officer | |
| Carol Vallone, Director | |
| Dominic Sergi, Independent Director | |
Cresco Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cresco Labs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Cresco Stock
Cresco Labs financial ratios help investors to determine whether Cresco Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cresco with respect to the benefits of owning Cresco Labs security.